ANAB
AnaptysBio, Inc. · Healthcare
Chief Medical Officer Paul F. Lizzul sold $86K of AnaptysBio, Inc.
Sold$86,425
$38.93Price
2,220Shares
−13%Stake
What ANAB did after the filing
- The stock from Tue, Sep 17 close, $25.00
- −17.9%
- S&P 500, same days
- +3.6%
Measured over 30 trading days, to the Oct 29 close.
Traded Mon, Sep 16. Filed Tue, Sep 17, 2:42 PM ET, during the session. Returns use the Sep 17 close and the Oct 29 close. Not investment advice.